AF
ABMD

Allworth Financial’s Abiomed Inc ABMD Stock Holding History

Allworth Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed -$3K – 3262
2022
Q3 		$3K Sell
12
-4
-25% -$1.08K ﹤0.01% 2085
2022
Q2 		$4K Sell
16
-93
-85% -$25.1K ﹤0.01% 1862
2022
Q1 		$36K Buy
109
+107
+5,350% +$32.9K ﹤0.01% 1018
2021
Q4 		$1K Hold
2
– – ﹤0.01% 1887
2021
Q3 		$1K Buy
+2
New +$678 ﹤0.01% 1827

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's ABMD Position: Q4 2022 in Review

Allworth Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12 shares — an estimated $3K sold.

Allworth Financial first reported a position in ABMD in Q3 2021 and held it in 5 quarters. The position peaked at $36K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Allworth Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Allworth Financial sold 12 Abiomed Inc shares in Q4 2022, an estimated $3K.
  • Allworth Financial first reported a position in Abiomed Inc in Q3 2021 and held it in 5 quarters.
  • Allworth Financial's Abiomed Inc position peaked at $36K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Allworth Financial's 13F filing for Q4 2022, filed 13 Jan 2023.